Messenger
The inside story of an unprecedented feat of science and business.
At the start of 2020, Moderna was a biotech unicorn with dim prospects. Yes, there was the promise of its disruptive innovation that could transform medicine by using something called messenger RNA, one of the body''s building blocks of life, to combat disease. But its stock was under water. There were reports of a toxic work cultur...
The inside story of an unprecedented feat of science and business.
At the start of 2020, Moderna was a biotech unicorn with dim prospects. Yes, there was the promise of its disruptive innovation that could transform medicine by using something called messenger RNA, one of the body''s building blocks of life, to combat disease. But its stock was under water. There were reports of a toxic work cultur...
